News

DaraEx and Mezagitamab

We are pleased to announce the publication of a new study ⧉ highlighting the effectiveness of DaraEx in overcoming interference caused by mezagitamab during serological pre-transfusion testing.

T Cell Staining Reagent available now

Visit our Shop to discover Dyemer, imusyn's novel T cell staining reagent.

Or have a look at our unmatched panel of recombinant HLA class I and class II proteins.

DaraEx plus

A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉.

DaraEx plus is available from inno-train ⧉.

imuPep Class I Peptide Binding Analysis

Our innovative, high-throughput service for you to confirm your target peptides, e.g. in vaccine and cancer research.

New IFU Versions and Languages

New Versions of the IFU for DaraEx plus and DaraEx are now available (release 2024/07/01).

Certificate Available for Download

EN ISO 13485:2016, issued May 09^th, 2023

Certificate Directive 98/79/EC, issued May 20^th, 2022

Welcome to imusyn.

Our mission is to develop and produce outstanding diagnostic tests in the field of transfusion medicine and organ transplantation. We also support the development of in-vitro diagnostics and provide customized recombinant protein production.